Each year, at precisely the same moment — 12 p.m. on the East coast, 9 a.m. on the West — thousands of graduating medical school students across the country simultaneously tear open an envelope. The single sheet of paper inside informs each graduate where he or she will do their residencies. This rite of passage for medical students will mark a new chapter in their already remarkable stories. Here are three.
Based in part on an exceptional faculty with broad strengths in the philosophy of science, history of philosophy, philosophy of mind, and ethics, the University of California San Diego Department of Philosophy increased its international prestige by ranking as one of the top 20 Ph.D. philosophy programs in the United States.
Fueled by a multimillion dollar grant from the state’s stem cell agency, researchers at University of California San Diego School of Medicine, in collaboration with local biotechnology company Oncternal Therapeutics, have launched a phase Ib/II clinical trial to evaluate the combined effectiveness of a standard of care drug with a novel monoclonal antibody that target B-cell malignancies, which include leukemias and lymphomas.
Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The findings, they say, represent an important proof-of-concept for the compound as there are currently no Food and Drug Administration-approved treatments for NAFLD and NASH.
UC San Diego Health is the first hospital in California to use the fifth generation troponin test to diagnose heart attack. Approved in the United States in 2017, the more sensitive test can detect heart attack within an hour, as opposed to three to six hours.
On March 12, 2018, UC San Diego Health will welcome its first patients to the Koman Family Outpatient Pavilion. Located on the La Jolla campus, the new 156,000-square-foot facility represents the most recent addition to the university’s world-class medical campus. In the past five years, UC San Diego Health has invested more than $1.3 billion dollars in patient care facilities for the community.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
